Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLXY vs GSK✓SelectedUSD · GSKGLXY vs GSK performance historyLatest closeAs of-0.84%11/17
Stock and ETF performance explorer

GLXY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-42.9%
GSK return
+40.1%
Excess return
-83.0%
Maximum drawdown
-69.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-2.3%+1.5%-1.6%
7D-7.7%-3.0%-4.6%-8.6%
30D-19.3%+0.4%-19.6%-18.6%
3M-40.4%-1.2%-39.2%-39.9%
6M-56.0%+0.9%-56.9%-55.6%
YTD-41.7%+4.0%-45.7%-40.3%
1Y-48.0%+7.3%-55.3%-46.9%
All-42.9%+40.1%-83.0%-44.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling